Categories Earnings, Technology

Earnings: SurveyMonkey reports 17% top line growth

Cloud-based software as a service company that specializes in online survey development, SurveyMonkey (NASDAQ: SVMK), reported first-quarter losses that were narrower than what the street anticipated. Adjusted net loss for the quarter was 2 cents per share, compared to 15 cents per share projected by the street.

SurveyMonkey paying users and average revenue per userQ1 revenues improved 17% to $68.6 million, edging past the average analysts’ expectation of $68.23 million. Enterprise sales revenue was approximately 16% of total revenue, up from about 13% in Q4.

The stock gained 7.9% during extended trading hours on Wednesday. SVMK shares have gained 45% since the beginning of this year.

The company, which debuted on Nasdaq in September last year, said its paid users at the end of the quarter were 670,862, 10% higher than the same period last year. The average revenue per user (ARPU) grew 8% year-over-year to $423.

CEO Zander Luries said, “Our paying user growth continues to accelerate driven by sales of SurveyMonkey Enterprise and adoption of our collaborative Teams plans with approximately 90% of the net adds in the quarter from annual plans.”

Outlook

For the second quarter, the company expects revenue in the range of $72-73 million, suggesting 15-16% year-over-year growth. Non-Gaap operating margin is projected to be negative four to negative two percent.

READ: LYFT POSTS MASSIVE LOSSES IN ITS MAIDEN EARNINGS REPORT

For the full year, revenues are projected in the range of $298-304 million, up 17-20% year-over-year.

During the previous earnings conference call, the management had laid out its plans for the company’s growth. The management plans to invest in efforts that drive enterprise sales, fuel growth in its core self-serve channel, and expand its international business.

Also Read:  Cloudera (CLDR) swings to profit in Q2 on strong revenue growth; results beat

SurveyMonkey expects to generate significant cash flow over the course of the year while aiming to position the company for an even stronger 2020.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Major earnings conferences to watch this week

After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through strategic partnerships and technological innovation. Its performance so

The COVID-19 pandemic gave these companies an unexpected opportunity

The COVID-19 pandemic raged through the first half of this year and continues to impact the world without signs of abating. Amid this health crisis, several companies reported strong results

Top